AAAAAA
Results:
1-24
|
Results: 24
Authors:
Higaki, K
Yamashita, S
Amidon, GL
Citation: K. Higaki et al., Time-dependent oral absorption models, J PHARMA PH, 28(2), 2001, pp. 109-128
Authors:
Choe, SY
Neudeck, BL
Welage, LS
Amidon, GE
Barnett, JL
Amidon, GL
Citation: Sy. Choe et al., Novel method to assess gastric emptying in humans: the Pellet Gastric Emptying Test, EUR J PH SC, 14(4), 2001, pp. 347-353
Authors:
Takamatsu, N
Kim, ON
Welage, LS
Idkaidek, NM
Hayashi, Y
Barnett, J
Yamamoto, R
Lipka, E
Lennernas, H
Hussain, A
Lesko, L
Amidon, GL
Citation: N. Takamatsu et al., Human jejunal permeability of two polar drugs: Cimetidine and ranitidine, PHARM RES, 18(6), 2001, pp. 742-744
Authors:
Chu, XY
Sanchez-Castano, GP
Higaki, K
Oh, DM
Hsu, CP
Amidon, GL
Citation: Xy. Chu et al., Correlation between epithelial cell permeability of cephalexin and expression of intestinal oligopeptide transporter, J PHARM EXP, 299(2), 2001, pp. 575-582
Authors:
Lobenberg, R
Kramer, J
Shah, VP
Amidon, GL
Dressman, JB
Citation: R. Lobenberg et al., Dissolution testing as a prognostic tool for oral drug absorption: Dissolution behavior of glibenclamide, PHARM RES, 17(4), 2000, pp. 439-444
Authors:
Amidon, GL
Citation: Gl. Amidon, Dissolution studies as surrogate for bioequivalence, EUR J DRUG, 25(1), 2000, pp. 65-65
Authors:
Desai, MP
Hilfinger, JM
Amidon, GL
Levy, RJ
Labhasetwar, V
Citation: Mp. Desai et al., Immune response with biodegradable nanospheres and alum: studies in rabbits using staphylococcal enterotoxin B-toxoid, J MICROENC, 17(2), 2000, pp. 215-225
Authors:
Jinno, J
Oh, DM
Crison, JR
Amidon, GL
Citation: J. Jinno et al., Dissolution of ionizable water-insoluble drugs: The combined effect of pH and surfactant, J PHARM SCI, 89(2), 2000, pp. 268-274
Authors:
Hilgendorf, C
Spahn-Langguth, H
Regardh, CG
Lipka, E
Amidon, GL
Langguth, P
Citation: C. Hilgendorf et al., Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: Permeabilities via diffusion, inside- and outside-directed carrier-mediated transport, J PHARM SCI, 89(1), 2000, pp. 63-75
Authors:
Ezra, A
Hoffman, A
Breuer, E
Alferiev, IS
Monkkonen, J
El Hanany-Rozen, N
Weiss, G
Stepensky, D
Gati, I
Cohen, H
Tormalehto, S
Amidon, GL
Golomb, G
Citation: A. Ezra et al., A peptide prodrug approach for improving bisphosphonate oral absorption, J MED CHEM, 43(20), 2000, pp. 3641-3652
Authors:
Pikal-Cleland, KA
Rodriguez-Hornedo, N
Amidon, GL
Carpenter, JF
Citation: Ka. Pikal-cleland et al., Protein denaturation during freezing and thawing in phosphate buffer systems: Monomeric and tetrameric beta-galactosidase, ARCH BIOCH, 384(2), 2000, pp. 398-406
Authors:
Lobenberg, R
Amidon, GL
Vieira, M
Citation: R. Lobenberg et al., Solubility as a limiting factor to drug absorption, DRUG PHARM, 106, 2000, pp. 137-153
Authors:
Yu, LX
Amidon, GL
Citation: Lx. Yu et Gl. Amidon, Analytical solutions to mass transfer, DRUG PHARM, 102, 2000, pp. 23-53
Authors:
Yu, LX
Gatlin, L
Amidon, GL
Citation: Lx. Yu et al., Predicting oral drug absorption in humans, DRUG PHARM, 102, 2000, pp. 377-409
Authors:
Surendran, N
Covitz, KMY
Han, HK
Sadee, W
Oh, DM
Amidon, GL
Williamson, RM
Bigge, CF
Stewart, BH
Citation: N. Surendran et al., Evidence for overlapping substrate specificity between large neutral aminoacid (LNAA) and dipeptide (hPEPT1) transporters for PD 158473, an NMDA antagonist, PHARM RES, 16(3), 1999, pp. 391-395
Authors:
Amidon, GL
Walgreen, CR
Citation: Gl. Amidon et Cr. Walgreen, Untitled, PHARM RES, 16(2), 1999, pp. 175-175
Authors:
Kaus, LC
Gillespie, WR
Hussain, AS
Amidon, GL
Citation: Lc. Kaus et al., The effect of in vivo dissolution, gastric emptying rate, and intestinal transit time on the peak concentration and area-under-the-curve of drugs with different gastrointestinal permeabilities, PHARM RES, 16(2), 1999, pp. 272-280
Authors:
Yu, LX
Amidon, GL
Citation: Lx. Yu et Gl. Amidon, A compartmental absorption and transit model for estimating oral drug absorption, INT J PHARM, 186(2), 1999, pp. 119-125
Authors:
Markland, P
Amidon, GL
Yang, VC
Citation: P. Markland et al., Modified polypeptides containing gamma-benzyl glutamic acid as drug delivery platforms, INT J PHARM, 178(2), 1999, pp. 183-192
Authors:
Lipka, E
Amidon, GL
Citation: E. Lipka et Gl. Amidon, Setting bioequivalence requirements for drug development based on preclinical data: optimizing oral drug delivery systems, J CONTR REL, 62(1-2), 1999, pp. 41-49
Authors:
Han, HK
Rhie, JK
Oh, DM
Saito, G
Hsu, CP
Stewart, BH
Amidon, GL
Citation: Hk. Han et al., CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs, J PHARM SCI, 88(3), 1999, pp. 347-350
Authors:
Markland, P
Zhang, YH
Amidon, GL
Yang, VC
Citation: P. Markland et al., A pH- and ionic strength-responsive polypeptide hydrogel: Synthesis, characterization, and preliminary protein release studies, J BIOMED MR, 47(4), 1999, pp. 595-602
Authors:
Axelrod, HR
Kim, JS
Longley, CB
Lipka, E
Amidon, GL
Kakarla, R
Hui, YW
Weber, SJ
Choe, S
Sofia, MJ
Citation: Hr. Axelrod et al., Intestinal transport of gentamicin with a novel, glycosteroid drug transport agent, PHARM RES, 15(12), 1998, pp. 1876-1881
Authors:
Taki, Y
Sakane, T
Nadai, T
Sezaki, H
Amidon, GL
Langguth, P
Yamashita, S
Citation: Y. Taki et al., First-pass metabolism of peptide drugs in rat perfused liver, J PHARM PHA, 50(9), 1998, pp. 1013-1018
Risultati:
1-24
|